• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?

作者信息

Bhansali Anil, Venkatesh S, Dutta Pinaki, Dhillon M S, Das Sambit, Agrawal Aditya

机构信息

Department of Endocrinology, PGIMER, Chandigarh, India.

出版信息

Diabetes Res Clin Pract. 2009 Jan;83(1):e13-6. doi: 10.1016/j.diabres.2008.10.005. Epub 2008 Dec 9.

DOI:10.1016/j.diabres.2008.10.005
PMID:19081156
Abstract

This study compares the efficacy of 0.01% rh-PDGF-BB with standard wound care in 20 patients with diabetes mellitus with neuropathic large plantar ulcers off-loaded with modified total contact cast. The incidence, duration and rate of healing were compared. An accelerated rate of healing in rhPDGF group was observed.

摘要

相似文献

1
Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?
Diabetes Res Clin Pract. 2009 Jan;83(1):e13-6. doi: 10.1016/j.diabres.2008.10.005. Epub 2008 Dec 9.
2
Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.重组人血小板衍生生长因子治疗下肢溃疡的临床评估
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):143S-149S; discussion 150S-151S. doi: 10.1097/01.prs.0000222526.21512.4c.
3
Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.重组人血小板衍生生长因子-BB（贝卡普勒明）局部凝胶制剂治疗慢性糖尿病神经性溃疡患者的疗效和安全性。一项III期随机安慰剂对照双盲研究。
Diabetes Care. 1998 May;21(5):822-7. doi: 10.2337/diacare.21.5.822.
4
Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers.外用重组人血小板衍生生长因子-BB（贝卡普勒明）在下肢慢性混合性动静脉糖尿病溃疡愈合中的应用。
J Foot Ankle Surg. 1999 May-Jun;38(3):227-31. doi: 10.1016/s1067-2516(99)80058-1.
5
Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?生长因子在糖尿病足溃疡治疗中的应用：新技术，有望成功吗？
Int J Low Extrem Wounds. 2007 Mar;6(1):37-53. doi: 10.1177/1534734606298416.
6
Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.重组人血小板衍生生长因子-BB（贝卡普勒明）用于治疗慢性下肢糖尿病溃疡：一项开放性疗效临床评估
Wound Repair Regen. 2000 May-Jun;8(3):162-8. doi: 10.1046/j.1524-475x.2000.00162.x.
7
[Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].[重组生长因子的批准。自2000年1月起，糖尿病足溃疡患者可用基因技术制造的生长因子贝卡普勒明（Regranex）进行治疗]
Internist (Berl). 2000 Jan;41(1):A38.
8
Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group.广泛清创及治疗对糖尿病足溃疡愈合的影响。糖尿病溃疡研究组。
J Am Coll Surg. 1996 Jul;183(1):61-4.
9
[New developments in the treatment of diabetic foot ulcers].[糖尿病足溃疡治疗的新进展]
Ned Tijdschr Geneeskd. 2000 Feb 26;144(9):409-12.
10
Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.贝卡普勒明：重组血小板衍生生长因子，一种治疗糖尿病足溃疡愈合的新方法。
Expert Opin Biol Ther. 2002 Feb;2(2):211-8. doi: 10.1517/14712598.2.2.211.

引用本文的文献

1
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis.12种干预措施治疗糖尿病足溃疡的疗效比较：一项网状Meta分析
PeerJ. 2025 Aug 11;13:e19809. doi: 10.7717/peerj.19809. eCollection 2025.
2
Comparison of the efficacy and safety of different growth factors in the treatment of diabetic foot ulcers: an updated network meta-analysis.不同生长因子治疗糖尿病足溃疡的疗效与安全性比较：一项更新的网状Meta分析
Front Endocrinol (Lausanne). 2025 Jun 25;16:1614597. doi: 10.3389/fendo.2025.1614597. eCollection 2025.
3
Comparative efficacy of growth factor therapy in healing diabetes-related foot ulcers: A network meta-analysis of randomized controlled trials.
生长因子治疗糖尿病相关足部溃疡愈合疗效的比较：一项随机对照试验的网络荟萃分析。
Diabetes Metab Res Rev. 2023 Jul;39(5):e3670. doi: 10.1002/dmrr.3670. Epub 2023 Jun 5.
4
HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study.水凝胶中 HATMSC 分泌因子治疗慢性创面的体外研究。
Int J Mol Sci. 2021 Nov 12;22(22):12241. doi: 10.3390/ijms222212241.
5
The Role of Recombinant Proteins and Growth Factors in the Management of Diabetic Foot Ulcers: A Systematic Review of Randomized Controlled Trials.重组蛋白和生长因子在糖尿病足溃疡治疗中的作用：随机对照试验的系统评价
J Diabetes Res. 2020 Jul 11;2020:6320514. doi: 10.1155/2020/6320514. eCollection 2020.
6
Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers.糖尿病皮肤溃疡中Wnt/β-连环蛋白信号通路的调控机制
Front Pharmacol. 2018 Oct 17;9:1114. doi: 10.3389/fphar.2018.01114. eCollection 2018.
7
Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.胰十二指肠切除术后血清细胞因子的变化：日本胰十二指肠切除术（JAPAN-PD）的一项附属研究
Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.
8
Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials.糖尿病足溃疡的生长因子：随机临床试验的混合治疗比较分析。
Br J Clin Pharmacol. 2018 Mar;84(3):434-444. doi: 10.1111/bcp.13470. Epub 2018 Jan 5.
9
Syndesome Therapeutics for Enhancing Diabetic Wound Healing.用于促进糖尿病伤口愈合的综合征治疗方法。
Adv Healthc Mater. 2016 Sep;5(17):2248-60. doi: 10.1002/adhm.201600285. Epub 2016 Jul 6.
10
Growth factors for treating diabetic foot ulcers.用于治疗糖尿病足溃疡的生长因子。
Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD008548. doi: 10.1002/14651858.CD008548.pub2.